Muscular dystrophies

Current Opinion in Neurology

Volumn 15, Issue 5, 2002, Pages 539-544

  Nishino, Ichizo ^a   Ozawa, Eijiro ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

dystroglycan; Calpain 3; Cavolin 3; Collagen VI; Glycosylation; Titin

Indexed keywords

ALPHA DYSTROGLYCAN; CAVEOLIN 3; COLLAGEN TYPE 6; CONNECTIN; DYSTROGLYCAN; UNCLASSIFIED DRUG;

ALLELISM; GENE ISOLATION; GENE MUTATION; GENETIC DISORDER; HUMAN; MOLECULAR MECHANICS; MUSCULAR DYSTROPHY; PATHOLOGICAL ANATOMY; PHENOTYPE; PROTEIN GLYCOSYLATION; REVIEW;

ALLELES; ANIMALS; CALPAIN; CAVEOLIN 3; CAVEOLINS; COLLAGEN TYPE VI; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; DYSTROPHIN; GLYCOSYLATION; HUMANS; ISOENZYMES; MEMBRANE GLYCOPROTEINS; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUTATION; PROTEIN KINASES;

EID: 0036799934     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200210000-00004     Document Type: Review

References (45)

1. Ozawa E, Nishino I, Nonaka I. Sarcolemmopathy: muscular dystrophies with cell membrane defects. Brain Pathol 2001; 11:218-230.
2. Williamson RA, Henry MD, Daniels KJ, et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997; 6:831-841.
3. Brockington M, Blake DJ, Brown SC, Muntoni F. The gene for a novel glycosyltransferase is mutated in congenital muscular dystrophy MDC1C and limb girdle muscular dystrophy 21. Neuromuscul Disord 2002; 12:233.
4. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type. Clinical, genetic and pathologic considerations. Brain Dev 1981; 13:1-29.
5. Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy. Paediatr Univ Tokyo 1960; 4:5-8.
6. Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998; 394:388-392.
7. Kondo-lida E, Kobayashi K, Watanabe M, et al. Novel mutations and genotype-phenotype relationships in 107 familles with Fukuyama-type congenital muscular dystrophy. Hum Mol Genet 1999; 12:2303-2309.
8. Aravind L, Koonin EV. The fukutin protein family - predicted enzymes modifying cell-surface molecules. Curr Biol 1999; 9:R836-R837.
9. Hayashi YK, Ogawa M, Tagawa K, et al. Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001; 57:115-121.
10. Brockington M, Blake DJ, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin a2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet 2001; 69:1198-1209.
11. Brockington M, Yuva Y, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001; 10:2851-2859.
12. Driss A, Amouri, R, Ben Hamida C, et al. A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3. Neuromuscul Disord 2000; 10:240-246.
13. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev 1989; 11:147-153.
14. Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001; 1:717-724.
15. Kano H, Kobayashi K, Herrmann R, et al. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 2002; 291:1283-1286.
16. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE. Mutant glycosyltransferase and altered glycosylation of a-dystroglycan in the myodystrophy mouse. Nat Genet 2001; 28:151-154.
17. Engel J, Furthmayr H, Odermatt E, et al. Structure and macromolecular organization fo type VI collagen. Ann NY Acad Sci 1985; 460:25-37.
18. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 1997; 272:26522-26529.
19. Ullrich O. Kongenitale, atonisch-sklerotische Muskeldystropie, ein weitere Typus der heredodegenerativen Erkrankungen des neuromuskulären Systems. Z ges Neurol Psychiatr 1930; 126:171-201.
20. Nonaka I, Une Y, Ishihara T, et al. A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy). Neuropediatrics 1981; 12:197-208.
21. Higuchi I, Suehara M, Iwaki H, et al. Collagen VI deficiency in Ullrich's disease. Ann Neurol 2001; 49:544.
22. Higuchi I. Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol 2001; 50:261-265.
23. Vanegas OC, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad USA 2001; 98:7516-7521.
24. Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease: Collagen VI deficiency. EM suggests a new basis for muscular weakness. Neurology 2002 (in press)
25. Bethlem J, van Wijngaarden GK. Genign myopathy, with autosomal dominant inheritance: a report on three pedigrees. Brain 1976; 99:91-100.
26. Scacheri PC, Gillanders EM, Subramony SH, et al. Novel mutations in collagen VI genes. Expansion of the Bethlem myopathy phenotype. Neurology 2002; 58:593-602.
27. Galbiati F, Razani B, Lisanti MP. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 2001; 7:435-441.
28. Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad USA 1995; 92:7819-7823.
29. Galbiati F, Volonté D, Chu JB, et al. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad USA 2000; 97:9689-9694.
30. Matsuda C, Hayashi YK, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001; 10:1761-1766.
31. Vorgerd M, Ricker K, Ziemssen F, et al. A sporadic case of rippling muscle disease by a de novo caveolin-3 mutation. Neurology 2001; 57:2273-2277.
32. Minetti C, Sotgia F, Bruno C, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998; 18:365-368.
33. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000; 54:1373-1376.
34. Tateyama M, Aoki M, Nishino I, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002; 58:323-325.
35. Vorgerd M, Bolz H, Patzold T, et al. Phenotypic variability in rippling muscle disease. Neurology 1999; 52:1453-1459.
36. Betz RC, Schoser BGH, Kasper D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001; 28:218-219.
37. Sorimachi H, Kinbara K, Kimura S, et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94 specific sequence. J Biol Chem 1995; 270:31158-31162.
38. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81:27-40.
39. Fardeau M, Hillaire D, Mignard C, et al. Juvenile limb-girdle muscular dystrophy clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996; 119:295-308.
40. Gerull B, Gramlich M, Atherton J, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002; 30:201-204.
41. Xu X, Meiler SE, Zhong TP, et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet 2002; 30:205-209.
42. Garvey SM, Rajan C, Lerner AP, et al. The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. Genomics 2002; 79:146-149.
43. Hackman P, Vihola A, Varavuori H et al. Tibial muscular dystrophy (TMD) is a titinopathy - caused by mutations in TTN, the gene encoding the giant skeletal muscle protein titin. Am J Hum Genet; (in press).
44. Udd B, Partanen J, Halonen P, et al. Tibial muscular dystrophy-late adult onset distal myopathy in 66 Finnish patients. Arch Neurol 1993; 6:604-608.
45. Haravuori H, Vihola A, Straub V, et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy. Titin is the candidate gene. Neurology 2001; 56:869-877.